These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 29269135

  • 1. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A, Rausalu K, Merits A, Higgs S, Vanlandingham D, Bakar SA, Zandi K.
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [Abstract] [Full Text] [Related]

  • 2. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA, Bahrani H, Abdulrahman AY, Mohamed Z, Teoh TC, Othman S, Rashid NN, Rahman NA, Yusof R.
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [Abstract] [Full Text] [Related]

  • 3. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC, Chen MC, Li S, Lin CC, Wang TT.
    Antivir Ther; 2017 Mar; 22(8):689-697. PubMed ID: 28406093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS, Kaukinen P, Gläsker S, Bespalov M, Hanski L, Wennerberg K, Kümmerer BM, Ahola T.
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [Abstract] [Full Text] [Related]

  • 7. A combination of doxycycline and ribavirin alleviated chikungunya infection.
    Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R.
    PLoS One; 2015 Feb; 10(5):e0126360. PubMed ID: 25970853
    [Abstract] [Full Text] [Related]

  • 8. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y, Orba Y, Sasaki M, Kobayashi S, Carr MJ, Nobori H, Sato A, Hall WW, Sawa H.
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of andrographolide against chikungunya virus infection.
    Wintachai P, Kaur P, Lee RC, Ramphan S, Kuadkitkan A, Wikan N, Ubol S, Roytrakul S, Chu JJ, Smith DR.
    Sci Rep; 2015 Sep 18; 5():14179. PubMed ID: 26384169
    [Abstract] [Full Text] [Related]

  • 12. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ, Wang YM, Lu JW, Wu TY, Lin LI, Kuo SC, Lin CC.
    PLoS One; 2015 Sep 18; 10(7):e0133511. PubMed ID: 26208101
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG, Choudhary S, Vilela GG, Passos GFS, Costa CACB, Freitas JD, Coelho GL, Brandão JA, Anderson L, Bassi ÊJ, Araújo-Júnior JX, Tomar S, Silva-Júnior EFD.
    Eur J Med Chem; 2023 Oct 05; 258():115572. PubMed ID: 37364511
    [Abstract] [Full Text] [Related]

  • 14. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC, White-Scholten L, Tas A, Hoornweg TE, Ferla S, Kovacikova K, Smit JM, Brancale A, Snijder EJ, van Hemert MJ.
    Viruses; 2020 Mar 17; 12(3):. PubMed ID: 32191995
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus.
    Rothan HA, Bahrani H, Shankar EM, Rahman NA, Yusof R.
    Antiviral Res; 2014 Aug 17; 108():173-80. PubMed ID: 24929084
    [Abstract] [Full Text] [Related]

  • 16. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ, Rodriquez JL, Pomeroy JJ, Hanrahan KC, Brown AN.
    Antivir Chem Chemother; 2018 Aug 17; 26():2040206618807580. PubMed ID: 30354193
    [Abstract] [Full Text] [Related]

  • 17. Antiviral activity of stearylamine against chikungunya virus.
    Jeengar MK, Kurakula M, Patil P, More A, Sistla R, Parashar D.
    Chem Phys Lipids; 2021 Mar 17; 235():105049. PubMed ID: 33422549
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
    Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P.
    PLoS One; 2011 Mar 17; 6(12):e28923. PubMed ID: 22205980
    [Abstract] [Full Text] [Related]

  • 19. Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro.
    Troost B, Mulder LM, Diosa-Toro M, van de Pol D, Rodenhuis-Zybert IA, Smit JM.
    Sci Rep; 2020 Apr 14; 10(1):6364. PubMed ID: 32286447
    [Abstract] [Full Text] [Related]

  • 20. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS, Thaa B, Amrun SN, Simarmata D, Rausalu K, Nyman TA, Merits A, McInerney GM, Ng LFP, Ahola T.
    J Virol; 2016 Nov 01; 90(21):9743-9757. PubMed ID: 27535052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.